These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 10940745

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
    Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS.
    Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial.
    Gulati A, Sinha A, Sreenivas V, Math A, Hari P, Bagga A.
    Clin J Am Soc Nephrol; 2011 Jan; 6(1):63-9. PubMed ID: 20847092
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction prednisone dosing for childhood nephrotic syndrome: how low should we go?
    Sibley M, Roshan A, Alshami A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Matsell DG, Mammen C, Pediatric Nephrology Clinical Pathway Development Team.
    Pediatr Nephrol; 2018 Sep; 33(9):1539-1545. PubMed ID: 29789934
    [Abstract] [Full Text] [Related]

  • 9. Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.
    Borovitz Y, Alfandary H, Haskin O, Levi S, Kaz S, Davidovits M, Dagan A.
    Eur J Pediatr; 2020 Feb; 179(2):279-283. PubMed ID: 31728673
    [Abstract] [Full Text] [Related]

  • 10. [Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children].
    Norero C, Delucchi A, Lagos E, Rosati P.
    Rev Med Chil; 1996 May; 124(5):567-72. PubMed ID: 9035508
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
    Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB.
    Pediatr Nephrol; 2003 Aug; 18(8):833-7. PubMed ID: 12774223
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
    Webb NJ, Frew E, Brettell EA, Milford DV, Bockenhauer D, Saleem MA, Christian M, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Booth J, Jones C, McKeever K, Cook W, Ives NJ, PREDNOS 2 study group.
    Trials; 2014 Apr 27; 15():147. PubMed ID: 24767719
    [Abstract] [Full Text] [Related]

  • 20. [The effect of treatment methods on frequency of relapse in nephrotic syndrome in children].
    Goszczyk A, Jung A, Bochniewska V, Straz-Zebrowska E.
    Pol Merkur Lekarski; 2000 Sep 27; 9 Suppl 1():25-6. PubMed ID: 11081338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.